Literature DB >> 1395280

An electromyographic analysis of the shoulder during cones and planes of arm motion.

M L Pearl1, J Perry, L Torburn, L H Gordon.   

Abstract

Shoulder motion has traditionally been described in reference to arbitrarily defined planes of motion (e.g., sagittal/flexion, coronal/abduction). This study examined shoulder muscle recruitment during conical arm movements, which include all planes of motion. Electromyographic (EMG) data was collected with intramuscular wire electrodes from ten muscles in five normal volunteers. Each muscle showed peak EMG activity in association with a direction of action consistent with its anatomic alignment. These findings were similar for movements in both the sagittal and coronal planes, calling into question conventionally held designations of shoulder muscles as flexors and abductors. Muscle recruitment was as follows: Clavicular pectoralis major, to move the arm medially along the horizontal; anterior deltoid, to move the arm obliquely upward inclined toward the midline; middle deltoid, to move the arm obliquely upward inclined away from the midline; posterior deltoid, to move the arm laterally along the horizontal; and teres major and latissimus dorsi, to move the arm obliquely downward away from the midline. Rotator cuff muscles were maximally active during elevation, consistent with the concept of a force couple.

Mesh:

Year:  1992        PMID: 1395280

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  Isokinetic muscle performance test can predict the status of rotator cuff muscle.

Authors:  Joo Han Oh; Jong Pil Yoon; Jae Yoon Kim; Chung Hee Oh
Journal:  Clin Orthop Relat Res       Date:  2010-06       Impact factor: 4.176

2.  Comparison of muscle activity in the empty-can and full-can testing positions using 18 F-FDG PET/CT.

Authors:  Choon-Key Lee; Eiji Itoi; Seong-Jang Kim; Su-Chan Lee; Kuen-Tak Suh
Journal:  J Orthop Surg Res       Date:  2014-10-01       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.